Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eabMCfbwoceToejxxNTn

  ADVERTISEMENT  
November 16, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  Science & Health 
  • Researchers get funding to study blood-clot process
    The British Heart Foundation has allotted about $317,000 for research at the Hull York Medical School to study a key step in the blood-clotting process. Researchers will focus on the way platelets clump together, which can lead to a heart attack or stroke. Researchers will also explore whether the protein thrombospondin-1 may help prevent clots. ThisIsHullAndEastRiding.co.uk (U.K.) (11/14) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Europe sees increase in cases of multidrug-resistant infections
    Multidrug-resistant infections have increased significantly in more than a third of European nations since 2008, according to the European Centre for Disease Prevention and Control, leading to greater reliance on last-line antibiotics. Overuse by hospitals and doctors has contributed to the problem, according to the agency. More than 60% of bloodstream infections in some countries were related to a kind of pneumonia bacteria that was resistant to multiple antibiotics. European cases of methicillin-resistant Staphylococcus aureus seem to have declined or stabilized. AlertNet/Reuters (11/16) LinkedInFacebookTwitterEmail this Story
  • Study: Change hand-off protocols to improve care
    Changing hand-off protocols among physicians and nurses between shifts could lead to better care and lower mortality, according to a study in the Archives of Internal Medicine. University of Michigan researchers who studied 23 shift hand-off sessions found physicians spent too much time talking about the first patients on the list and rushed through cases at the end, even though those patients may have needed more attention. HealthDay News (11/14) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
The Buzz(CORPORATE ANNOUNCEMENTS)

Distance Education Masters at George Washington University
For those enrolled in an SBB program or SBB certified. Twenty-two hours of distance education courses in areas such as molecular biology, current topics in transfusion medicine, immunology and a research project in an area of immunohematology. Learn More.


  Government & Regulatory 
  • Teleflex's vascular access catheter scores 510(k) clearance
    The FDA has cleared Teleflex to market its Nylus catheter, which is delivered peripherally to the central venous system. The device was first cleared in Europe in July and is intended to help minimize the risk of blood clot-related complications during infusions, among other applications. BeckersASC.com (11/15) LinkedInFacebookTwitterEmail this Story
  • Senators open to changes in regulation of compounders
    Republican and Democratic senators indicated at a hearing Thursday that they would be open to changes in the oversight of compounding pharmacies to avoid outbreaks such as the one tied to tainted steroid injections from the New England Compounding Center. Sen. Lamar Alexander, R-Tenn., said the FDA could be given the ability to certify states to regulate large-scale compounders, and it would have the power to decertify states that don't live up to the responsibility. Reuters (11/15) LinkedInFacebookTwitterEmail this Story
  • FDA panel: Data on effects of hepatitis B vaccine insufficient
    The FDA's Vaccines and Related Biologics Advisory Committee voted 13-1 to back the efficacy of the hepatitis B vaccine Heplisav, but members raised concerns about its safety and asked whether more trial data was needed involving blacks, Asians and Hispanics. The FDA could decide on the application by Feb. 24. MedPage Today (free registration) (11/15) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Audioconference on applying for NBF grants added to November lineup
    "How to Get That NBF Grant!" has been added to the November audioconference lineup. This free session, taking place Wednesday, Nov. 28, will review the grant application and scoring processes and provide tips to potential applicants. Led by NBF Grants Review Committee Chair James Zimring, M.D., Ph.D., this event is geared toward early-career researchers. Learn more. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
West Coast Account ManagerMacopharma USAUS - Nationwide
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Help Desk SpecialistAABBUS - MD
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Staff AccountantAABBUS - MD
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
One thing I am convinced more and more is true and that is this: The only way to be truly happy is to make others happy. When you realize that and take advantage of the fact, everything is made perfect."
--William Carlos Williams,
American poet and physician


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information